Volpara Health Technologies Limited (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies Limited (ASX: VHT)
Latest News
Technology Shares
2 ASX tech shares that might be buys in October 2021
Best Shares
Top ASX shares to buy in October 2021
Small Cap Shares
Broker names 2 small cap ASX shares to buy
Healthcare Shares
Volpara (ASX:VHT) share price under spotlight on lung screening expansion
Growth Shares
2 top ASX growth shares that might be worth buying
Small Cap Shares
2 buy-rated small cap ASX shares
Small Cap Shares
3 growing small cap ASX shares named as buys
Technology Shares
2 ASX shares that may be worth looking at this weekend
Small Cap Shares
3 small cap ASX shares to put on your watchlist this week
Growth Shares
2 ASX shares that could be buys in August 2021
Small Cap Shares
2 small cap ASX shares that this broker rates as buys
Growth Shares
2 great ASX shares to think about
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies Limited
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Teri Jo Thomas | Chief Executive OfficerManaging Director | Apr 2022 |
Teri joined the Board in October 2022. She has a
long history of executive management in healthcare IT ranging from strategy and operations to running global sales and marketing teams. This includes a 20-year career at Epic, a global leader in electronic health record (EHR) systems and other software solutions used by hospitals and healthcare organisations in the United States and internationally |
| Mr Craig Hadfield | Chief Financial OfficerJoint Company Secretary | Mar 2017 |
-
|
| Mr Fred Struve | General CounselJoint Company Secretary | Oct 2022 |
-
|
| Craig Hadfield | Chief Financial OfficerJoint Company Secretary |
-
|
|
| Fred Struve | General CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| No Top 20 | 27,534,688 | 10.84% |
| Patagorang Pty Ltd | 18,467,848 | 7.27% |
| Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> | 16,213,561 | 6.38% |
| Citicorp Nominees Pty Limited | 11,830,450 | 4.66% |
| HSBC Custody Nominees (Australia) Limited | 8,187,911 | 3.22% |
| Custodial Services Limited <Beneficiaries Holding A/C> | 8,154,911 | 3.21% |
| Bnp Paribas Noms (Nz) Ltd <Drp> | 7,061,556 | 2.78% |
| Prof Sir Michael Brady | 6,619,075 | 2.61% |
| Mr Marcus Sarner | 5,980,404 | 2.35% |
| National Nominees Limited | 4,728,818 | 1.86% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient | 4,420,193 | 1.74% |
| Sir Martin Francis Wood | 3,004,655 | 1.18% |
| Lady Kathleen Audrey Wood | 3,004,654 | 1.18% |
| BNP Paribas Noms Pty Ltd <Drp> | 2,527,511 | 0.99% |
| Prof Martin Yaffe | 1,966,483 | 0.77% |
| Mr John Anthony Dell | 1,928,864 | 0.76% |
| BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited | 1,917,409 | 0.75% |
| Prof Nico Karssemeijer | 1,806,806 | 0.71% |
| Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> | 1,519,964 | 0.60% |
| RX HOUSE TRUST PTY LTD | 880,758 | 0.35% |